NO20051009L - Syntese av indoliziner - Google Patents

Syntese av indoliziner

Info

Publication number
NO20051009L
NO20051009L NO20051009A NO20051009A NO20051009L NO 20051009 L NO20051009 L NO 20051009L NO 20051009 A NO20051009 A NO 20051009A NO 20051009 A NO20051009 A NO 20051009A NO 20051009 L NO20051009 L NO 20051009L
Authority
NO
Norway
Prior art keywords
following formula
indolizines
represented
synthesis
reacting
Prior art date
Application number
NO20051009A
Other languages
English (en)
Norwegian (no)
Inventor
Mitsunori Ono
Lijun Sun
Zhi-Qiang Xia
Teresa Przewloka
Shijie Zhang
Original Assignee
Synta Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synta Pharmaceuticals Corp filed Critical Synta Pharmaceuticals Corp
Publication of NO20051009L publication Critical patent/NO20051009L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20051009A 2002-09-13 2005-02-24 Syntese av indoliziner NO20051009L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41067902P 2002-09-13 2002-09-13
PCT/US2003/028252 WO2004024727A2 (en) 2002-09-13 2003-09-10 Synthesis of indolizines

Publications (1)

Publication Number Publication Date
NO20051009L true NO20051009L (no) 2005-04-04

Family

ID=31994182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051009A NO20051009L (no) 2002-09-13 2005-02-24 Syntese av indoliziner

Country Status (10)

Country Link
US (1) US20040152897A1 (es)
EP (1) EP1537105A2 (es)
JP (1) JP2006504692A (es)
KR (1) KR20050052498A (es)
CN (1) CN1681813A (es)
AU (1) AU2003267071A1 (es)
CA (1) CA2496764A1 (es)
MX (1) MXPA05002745A (es)
NO (1) NO20051009L (es)
WO (1) WO2004024727A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0414313A (pt) 2003-09-11 2006-11-07 Kemia Inc inibidores de citocinas
WO2005099824A1 (en) * 2004-03-30 2005-10-27 Synta Pharmaceuticals, Corp. 1-glyoxylamide indolizines for treating lung and ovarian cancer
MX2009001877A (es) 2006-08-21 2009-03-02 Synta Pharmaceuticals Corp Compuestos para el tratamiento de trastornos proliferativos.
US8581004B2 (en) 2008-02-21 2013-11-12 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
WO2011031086A2 (ko) * 2009-09-10 2011-03-17 주식회사 엘지화학 신규한 헤테로고리 유도체 및 이를 이용한 유기 발광 소자
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
CN111788204B (zh) 2018-02-26 2023-05-05 吉利德科学公司 作为hbv复制抑制剂的取代吡咯嗪化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003383A1 (en) * 1994-07-21 1996-02-08 Eli Lilly And Company INDOLIZINE sPLA2 INHIBITORS
WO1998047507A1 (en) * 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
EP1007525A1 (en) * 1997-08-29 2000-06-14 Zeneca Limited Aminometyl oxooxazolidinyl benzene derivatives
NZ531700A (en) * 2001-09-13 2006-10-27 Synta Pharmaceuticals Corp 1-Glyoxylamide indolizines for treating cancer

Also Published As

Publication number Publication date
CA2496764A1 (en) 2004-03-25
AU2003267071A1 (en) 2004-04-30
JP2006504692A (ja) 2006-02-09
EP1537105A2 (en) 2005-06-08
CN1681813A (zh) 2005-10-12
US20040152897A1 (en) 2004-08-05
WO2004024727A2 (en) 2004-03-25
WO2004024727A3 (en) 2004-06-03
MXPA05002745A (es) 2005-06-03
KR20050052498A (ko) 2005-06-02

Similar Documents

Publication Publication Date Title
WO2005074642A3 (en) Chemical compounds
NO20051009L (no) Syntese av indoliziner
DE602005005240D1 (de) 4'-C-substituierte 2-Haloadenosinderivate
NO20080789L (no) 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
DK1740544T3 (da) 2 pyridinylcycloalkylcarboxamidderivater, der er egnede som fungicider
RS51341B (en) INTERMEDIATE COMPOUNDS FOR THE TRANS-5-CHLOR-2-METHYL-2,3A, 12B-TETRAHYDRO-1H-DIBENZE [2,3; 6,7] OXEPINO [4,5-C] Pyrrole
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
CY1107403T1 (el) Μια μεθοδος δια την παρασκευη υπερινδοπριλης,των αναλογων ενωσεων αυτης και των αλατων αυτων με χρησιμοποιηση ενδιαμεσων ενωσεων 2,5-διοξο-οξαζολιδινης
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20054787D0 (no) Indenderivater som farmasotiske midler
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
WO1999000373A8 (fr) Derives de benzimidazole
NO20062202L (no) Amidometylsubstituerte 2-(4-sulfonylamino)-3-hydroksy-3,4-dihydro-2H-kromen-6-yl-derivater, fremgangsmate og mellomprodukter for deres fremstilling, og legemidler som inneholder disse forbindelsene
TW200619213A (en) A process for the preparation of organic compounds
WO2003059907A1 (fr) Composes heterocycliques azotes : procede de preparation et d'utilisation
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
NO20071817L (no) Fremgangsmate for a fremstille enantiomeriske imidazolforbindelser
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
EA200500688A1 (ru) Новый способ получения синтетических промежуточных соединений для пестицидов
EE05136B1 (et) Asendatud imidasopridiinhendite valmistamise meetod
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
NO20060586L (no) 7-substituerte-3-nitro-pyrazol[1,5-a]pyrimidiner
EP1533312A4 (en) HETERO-BICYCLIC COMPOUNDS
WO2001011968A3 (en) Heterocyclic spiro compounds as pesticides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application